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Introduction
The transcription factor Pax6 is conserved from invertebrates
to vertebrates and regulates key developmental processes in
several organs throughout phylogeny (Chi and Epstein, 2002).
In all of these organs, Pax6 acts as a potent cell fate
determinant, and often affects cell proliferation, yet it is not
well understood how Pax6 coordinates these diverse effects at
the molecular level in vivo. Pax6 contains two DNA-binding
domains, the paired domain (PD) and a paired-like
homeodomain (HD) linked via a glycine-rich domain, and acts
as an activator of gene expression by a proline-, serine- and
threonine-rich (PST) domain at the C-terminus (Bouchard et
al., 2003). Both the PD and HD bind to specific DNA target
sites (Chi and Epstein, 2002) and may also influence each
other’s binding to the DNA or cooperate on DNA binding
(Duncan et al., 1998; Jun and Desplan, 1996; Mikkola et al.,
2001; Mishra et al., 2002; Singh et al., 2000). Several splice
variants have been discovered for the Pax6 gene (Anderson et
al., 2002; Duncan et al., 2000; Epstein et al., 1994; Kozmik et
al., 1997; Mishra et al., 2002) resulting predominantly in a
truncated form lacking the paired domain (‘paired-less’) and a
form with a 14 amino acid (AA) insert into the PD [Pax6(5a),
see Fig. 1]. The canonical PD (without the 14 AA insert) binds
via its N-terminal PAI domain (Epstein et al., 1994) to DNA,
while the insertion of the 14 AA from exon 5a (now designated
as exon 5, but here still referred to as 5a) into the PAI domain
[PD(5a)] abolishes its DNA-binding and favors DNA-binding
of the C-terminal RED domain (Epstein et al., 1994) (Fig. 1A).
Distinct consensus sites have been identified for these domains,
with the N-terminal PAI domain binding to both consensus
sites (P6CON; 5aCON), while the C-terminal RED domain can
only activate targets with the 5aCON site (Epstein et al., 1994)
(Fig. 1A). Notably, the Pax6(5a) form is required for aspects
of postnatal differentiation in the eye (Singh et al., 2002), and
an important role of the same modification of PD-mediated
DNA binding was recently discovered in the developing
compound eye of Drosophila (Dominguez et al., 2004).
Despite the crucial function of Pax6 in the developing brain,
nothing is known about the specific roles of its DNA-binding
domains, since analysis has so far been performed exclusively
with the functional null alleles Pax6Sey, Pax6Sey-Neu in mice (Hill
et al., 1991; Schmahl et al., 1993) and the Pax6Sey rat (Matsuo
et al., 1993), all of which contain a truncated Pax6 protein
lacking the transactivator domain (TA) (Fig. 1E). The strongest
effects of Pax6 mutation in the brain are manifested in the
forebrain (Schmahl et al., 1993), where Pax6 expression starts
at embryonic day (E) 9 in the mouse (Walther and Gruss,
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1991). In the telencephalon, Pax6 is restricted to the dorsal
region, and this region is misspecified in the Pax6 mutants.
Severe defects in patterning are indicated by the expansion of
ventral transcription factors into the dorsal telencephalon or the
loss of boundary structures restricting cell migration between
these regions of Pax6Sey–/– mice (Chapouton et al., 1999; Heins
et al., 2002; Stoykova et al., 1996; Stoykova et al., 1997;
Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001).
Notably these Pax6 mutations also affect patterning in the
hindbrain, spinal cord and the ventral diencephalon (Briscoe et
al., 1999; Grindley et al., 1997; Osumi, 2001; Osumi et al.,
1997; Stoykova et al., 1996) implying a widespread role of
Pax6 in patterning.
In contrast, the recently discovered potent neurogenic role
of Pax6 appears more restricted to the telencephalon, and
seemingly contributes to the maintenance of neurogenesis into
adulthood exclusively in this part of the brain (Alvarez-Buylla
et al., 2001; Gage, 2002; Hack et al., 2004; Heins et al., 2002;
Nakatomi et al., 2002). The absence of functional Pax6 not
only severely impairs neurogenesis in the dorsal telencephalon,
its overexpression is also sufficient to drive embryonic
precursors, postnatal cortical astrocytes and adult neural stem
cells towards neurogenesis (Hack et al., 2004; Heins et al.,
2002). In addition, Pax6 is involved in the reduction of
proliferation in the telencephalon, since its loss-of-function
results in an increased number of precursors (Estivill-Torrus et
al., 2002; Götz et al., 1998; Heins et al., 2002), while its gain-
of-function reduces the number of progeny generated by a
single progenitor cell (Heins et al., 2002). To gain a better
understanding of potentially separate roles exerted by distinct
DNA-binding domains of the Pax6 transcription factor, we
examined here the function of its three DNA binding domains,
the PD, PD(5a) and HD in the developing forebrain.
Materials and methods
Animals
Pax6Sey mice were maintained as heterozygotes on a mixed
C57BL/6JxDBA/2J background, Pax6Aey18 mice (J.G., unpublished)
and Pax64Neu mice were maintained on a C3HeB/FeJ background).
Pax6tm1Gfs mice are referred here as Pax6(5a)–/– mice (Singh et
al., 2002) and were maintained as homozygotes on a C57BL/6
background. Analysis was performed with embryos from embryonic
day (E)10-16.
Immunohistochemistry and in situ hybridization
Embryonic brains were fixed in 4% paraformaldehyde in PBS (PFA)
and sections were cut with a vibratome or with a cryostat after
cryoprotection. Sections were processed for immunohistochemistry
(Götz et al., 1998; Hartfuss et al., 2001), using the primary antibodies
against the phosphorylated form of Histone H3 (PH3, rabbit, Biomol,
1:200), NeuN (mouse IgG1, 1:50, Chemicon), Mash1 (mouse IgG1,
1:2, kindly provided by F. Guillemot), Gsh2 (rabbit, 1:1000, kindly
provided by K. Campbell), Ngn2 (mouse IgG2a, 1:10, kindly
provided by D. Anderson), Olig2 (rabbit, 1:1000, kindly provided by
D. Rowitch), Ki67 (rat Tec-3, 1:50, Dako), β-galactosidase (rabbit,
1:300, Cappel; mouse IgG2a, 1:500, Promega), O4 (mouse IgM,
1:1000, kindly provided by J. Price), GFAP (mouse IgG1, 1:200,
Sigma), RC2 (mouse IgM, 1:500, kindly provided by P. Leprince),
Pax6 (rabbit, 1:300, Babco), reticulon1 (mAb 9-4, 1:10, kindly
provided by T. Hirata) and nestin (mouse IgG1, 1:4, Dev. Hybridoma
Bank). The respective secondary antibodies were used from Jackson
Immunoresearch, Inc. and Southern Biotechnology Associates, Inc.
Specimens were mounted in Aqua Poly/Mount (Polysciences,
Northampton, UK) and analyzed at a Confocal Microscope (Leica
TCS 4NT; Leica Microsystems; Heidelberg). Digoxigenin-labeled
RNA probe for SFRP2 was made and used as described (Chapouton
et al., 2001).
Retrovirus preparation and retroviral infection
The entire coding sequence of Pax6 (1873bp fragment) and Pax6(5a)
(1915 bp fragment) was cloned in sense orientation into the BglII
unique restriction site of the retroviral vector 1704 between the
upstream LTR and the EMC IRES sequence (gift of J. E. Majors)
(Ghattas et al., 1991). BOSC23 helper-free packaging cells (Pear et
al., 1993) were used for viral production by means of transient
transfection with the respective viral plasmid and resulted in a typical
titre of 1105/ml. Primary cells from cerebral cortex were isolated
and cultured as described previously (Heins et al., 2002), and infected
2 hours after plating at a concentration giving no more than 50 clones
per coverslip and analyzed after 1 week in vitro.
Data analysis
The quantification of neurons was performed in sections of the
cerebral cortex at E14 from wild-type (WT) and homozygous mutants
at corresponding rostral, intermediate and caudal levels stained
for NeuN. The thickness of the NeuN-positive cortical plate was
measured in confocal pictures taken in a defined (lateral) area of the
cortex by first drawing a line at right angles to the ventricular surface
(VS) from the VS to the pial surface. The length of this line was
determined by the ImageJ program and served as measure of the total
cortical thickness. A second line was drawn from the apical and basal
side of the NeuN-positive band, and its length served as a measure for
the thickness of the band of neurons, the cortical plate. The width of
the cortical plate was calculated as the proportion of the overall
thickness of the cerebral cortex (Table 1).
The quantification of PH3-labeled cells was performed by placing
a 150-µm-wide square covering the entire cortical thickness parallel
to the VS. All PH3-positive cells in this square were counted
separately for cells lining the ventricle (VZ cells) and cells at
abventricular positions (SVZ cells defined as PH3+ cells, five or more
cell diameters away from the VS) (see Smart, 1976) (Table 1).
For the clonal analysis in vitro, all clones per coverslip were
assessed for their cell type or size (Fig. 5) and the mean was calculated
per coverslip (excluding coverslips with more than 50 clones; Fig.
5C,D). Group comparisons were made with the unpaired t-test and P-
values smaller than 0.05 were considered significant (*), P-values
smaller than 0.001 were considered highly significant (***).
Results
The paired domain, but not the homeodomain plays
a crucial role in telencephalon development
To assess the role of the PD of Pax6 we analyzed the Pax6Aey18
mutant mice, which are characterized by the loss of a splice
acceptor site in front of exon 5a such that exon 5a and 6 are
excluded and a large part of the PD is deleted, whereas the HD
and TA remain unaffected (Fig. 1B) (J.G., unpublished). To
examine specifically the role of the Pax6(5a) isoform we used
the Pax6tm1Gfs mice [here referred to as Pax6(5a)–/–] carrying
a targeted deletion of the exon 5a (Fig. 1C) (Singh et al., 2002).
The Pax64Neu mutation carries a point mutation in the third
helix of the HD that abolishes its DNA-binding (Fig. 1D)
(Favor et al., 2001). These mutants were compared to the
Pax6Sey–/– mice, characterized by a truncated form of Pax6
lacking the TA domain (Fig. 1E), which has been identified as
a functional null by comparison to the Pax6–/– (e.g. Götz et
al., 1998; Briscoe et al., 1999).
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Neurogenesis
Neurogenesis was examined in these mutants by
immunohistochemistry for neuronal markers, such as NeuN
(Fig. 2) or βIII-tubulin (data not shown). Neurons accumulate
in the cortical plate (CP) forming a distinct band underneath
the pial surface (Fig. 2A) at midneurogenesis, embryonic day
(E) 14, in the WT cortex. The NeuN-positive band is distinctly
smaller in the cortex of homozygous Pax6Aey18–/– mouse
mutants (Fig. 2A,B), reflecting a significant decrease in the
number of neurons generated (Table 1). Since the neurogenesis
phenotype of Pax6Aey18–/– mice was reminiscent of the
functional null allele Pax6Sey (Fig. 2E), we quantified the
thickness of the cortical plate relative to the total cortical
thickness (see Materials and methods) in the lateral cortex at
rostral, intermediate and caudal levels (Table 1). Notably the
significant reduction of the thickness of the NeuN-positive
band compared to WT in the Pax6Aey18–/– cortex (P<0.001) and
the comparable reduction observed in Pax6Sey–/– cortex (Table
1), suggests that Pax6Aey18 is a functional null allele for cortical
neurogenesis. In contrast, we found no reduction in
neurogenesis in Pax6(5a)–/– mice (Table 1; Fig. 2C) or
Pax64Neu–/– mice (Table 1; Fig. 2A,D). Thus, the PD, but not
the HD of Pax6 is required for the regulation of neurogenesis
in the cerebral cortex.
Cell proliferation
Reduction of neurogenesis in the developing telencephalon is
accompanied by an increase in cell proliferation in mutants
bearing functional null alleles of Pax6 (Estivill-Torrus et al.,
2002; Götz et al., 1998). The number of precursors was
determined by immunostaining against the antigen Ki67
labeling actively dividing precursors in all phases of the cell
cycle (Gerlach et al., 1997) and the phosphorylated form of
histone H3 (PH3) (Hendzel et al., 1997). Since PH3 labels all
Table 1. Quantitative analysis of the phenotypes in neurogenesis and proliferation of mouse mutants with specific defects
in Pax6 DNA-binding domains
Thickness of cortical plate
(neurons)/thickness of
Proliferation/area (number
of PH3+ cells per radial
stripe of 150 µm) at
Proliferation/area (number
of PH3+ cells per radial
stripe of 150 µm) at
Proliferation/area
(total number of PH3+






















































All values are given as mean±s.d., n=12.
Fig. 1. Schematic drawings of the Pax6 mRNA in wild type (WT)
and mice harboring mutations in the distinct DNA-binding domains
of Pax6. (A) The mRNA of Pax6 consists of two DNA binding-
domains, the paired domain (PD) and the homeodomain (HD). The
PD is subdivided in two independent DNA-binding domains, the N-
terminal PAI and the C-terminal RED domain. The PAI domain is
able to bind to P6CON (Pax6 consensus site) and 5aCON (Pax6(5a)
consensus site), whereas the RED domain binds exclusively to
5aCON. By means of alternative splicing, 14 amino acids are
inserted into the N-terminal PAI domain (see yellow box) and
thereby abolish its DNA binding. The transactivation domain (TA),
important for gene activation, is located at the C-terminal end of
Pax6. (B) The Pax6Aey18 mutant is characterized by a large deletion in
the PD (exon 5a and exon 6), whereas the HD and TA are still
present. (C) The Pax6(5a)–/– lacks exon 5a in the PD due to gene
targeting (Singh et al., 2002), while the rest of the PD, HD and TA
are unaffected. (D) Pax64Neu mutant mice bear a point mutation in the
HD that abolishes DNA binding of the HD, while PD and TA are
intact (Favor et al., 2001). (E) The Pax6Sey mutant mice are
characterized by a truncated form of Pax6, lacking the HD and TA.
These mutants have a comparable phenotype to the full gene deletion
(Pax6–/–) and are therefore referred to as functional null alleles. PD,
paired domain; HD, homeodomain; TA, PST-rich transactivator
domain.
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precursors in late G2 and M-phase (Fig. 2), we could
distinguish between precursors located in the VZ, that undergo
interkinetic nuclear migration and perform M-phase at the
ventricular surface (VS; arrow in Fig. 2A), from precursors
located in the subventricular zone (SVZ) that undergo mitosis
at abventricular positions (arrowhead in Fig. 2A) (Haubensak
et al., 2004; Miyata et al., 2004; Noctor et al., 2004; Smart,
1976). In the Pax6Aey18–/– mutant cortex the increase in the
number of PH3-positive cells was obvious (Fig. 2A,B) and
highly statistically significant (Table 1). Interestingly, the
number of precursors in the VZ was not changed in the
Pax6Aey18–/– cortex, but the mutation results in a specific
increase in SVZ precursors (Fig. 2A,B; Table 1). This
phenotype is identical to the cortex of the Pax6Sey–/– mice (Fig.
2E) that also exhibited a marked increase in SVZ precursor
cells [2.7-fold increase in SVZ precursors in Pax6Aey18–/–
cortex compared to 2.4-fold increase in Pax6Sey–/– cortex;
Table 1 (Estivill-Torrus et al., 2002; Götz et al., 1998)], again
supporting a functional null phenotype in the PD mutant
Pax6Aey18–/– mice. In contrast, no changes in proliferation,
either in the VZ or SVZ, were detectable in mice solely lacking
exon 5a (Fig. 2A,C; Table 1) or in the HD mutant Pax64Neu–/–
(Fig. 2A,D; Table 1). Taken together, it appears that regulation
of neurogenesis and proliferation does not involve the HD, but
depends solely on PD function.
Patterning
Next we examined the role of the PD and HD in mediating
dorso-ventral patterning in the forebrain. Previous analysis
of the functional null Pax6Sey–/– described an almost
complete lack of neurogenin (Ngn) 2 expression in the dorsal
telencephalon, while expression of the transcription factors
Mash1, Gsh2 and Olig2, that is normally restricted to the
ventral telencephalon, expands into the dorsal telencephalon in
the absence of Pax6 function (Fig. 3D,D′, and data not shown)
(see Stoykova et al., 2000; Torresson et al., 2000; Yun et al.,
2001). Precisely this phenotype was observed in the cortex of
Pax6Aey18–/– mice (Fig. 3A,A′; see Fig. S1 in supplementary
material) while no changes in dorso-ventral expression patterns
of these transcription factors were observed in the cortex of the
Pax6(5a)–/– (Fig. 3B,B′) and the HD mutant Pax64Neu–/– (Fig.
3C,C′; Fig. S1). Since Ngn2 is a direct target of the canonical
form of the PD (Scardigli et al., 2003), these findings further
support the crucial role of the canonical PD of Pax6 in its
regulation. Consistent with the gradient of Pax6 in the cortex,
Ngn2 expression was still visible in the caudal-most and
medial regions of the cortex in the Pax6Sey–/– and Pax6Aey18–/–,
where Pax6 expression is lowest (see Fig. S2A,B,E in
supplementary material).
The telencephalic region where these two domains of
transcription factors normally abut differentiates various
features of a boundary (Lumsden and Krumlauf, 1996) with
formation of a radial glia fascicle and expression of specific
diffusible molecules thereby inhibiting most, but not all, cells
from crossing between the dorsal and the ventral telencephalon
(Chapouton et al., 1999; Chapouton et al., 2001; Fishell et al.,
1993). One characteristic marker is SFRP2, the soluble frizzled
related protein 2, expressed specifically at the ventral-most
region of the Pax6-positive territory (Chapouton et al., 2001;
Kim et al., 2001). SFRP2 expression failed to appear in the
Pax6Aey18–/– (Fig. 4A,A′), the Pax64Neu–/– (Fig. 4C,C′) and
Pax6Sey–/– telencephalon (Kim et al., 2001) (Fig. 4D,D′), while
it was normally expressed in the Pax6(5a)–/– telencephalon
(Fig. 4B,B′). In contrast the boundary marker protein reticulon-
1 (Hirata et al., 2002) was absent in the Pax6Aey18–/– as in the
Pax6Sey–/–, but was still detectable in the Pax6(5a)–/– and in
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Fig. 2. Neurogenesis and cell proliferation in
the cerebral cortex of mice harboring
mutations in the distinct DNA-binding
domains of Pax6. (A-E) Micrographs show
coronal sections of the lateral cerebral cortex
immunostained for NeuN (red) (neuronal
marker) and PH3 (green) (marker for cells in
M-phase) at embryonic day (E)14 in the
respective mouse mutants as indicated in the
panels. Note that the band of NeuN-positive
cells is reduced in the PD mutant
Pax6Aey18–/– (B) compared to WT cortex
(A), indicating a reduced neurogenesis that
appears comparable in extent to the
phenotype in the functional null Pax6Sey–/–
(E). In contrast, no such changes could be
observed for the cortex of Pax6(5a)–/– (C) or
the HD-mutant Pax64Neu–/– (D). In the
mutants with an impaired neurogenesis (the
PD mutant Pax6Aey18–/– and Pax6Sey–/–), we
observed an increase in precursors (green
PH3-positive cells in B,E), while no changes
in comparison to WT (A) were seen in the
cortex of Pax6(5a)–/– (C) and Pax64Neu–/–
(D). Note that the PH3-positive cells were
mostly increased in the subventricular zone (SVZ, arrowhead in A; increase in B and E), but not in the VZ (arrow in A). Thus, the PD of Pax6
is necessary and sufficient to mediate the effects of Pax6 on neurogenesis and cell proliferation in the cerebral cortex, while targets of the HD
seem to play no role in these aspects. The dashed white line (A-E) indicates the ventricular surface of the cortex. MZ, marginal zone; CP,
cortical plate ; SVZ, subventricular zone; VZ, ventricular zone; CTX, cortex; GE, ganglionic eminence. Scale bar: 100 µm.
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Fig. 3. Dorso-ventral patterning in the telencephalon of mice
harboring mutations in the distinct DNA-binding domains of Pax6.
Micrographs of coronal sections of the lateral telencephalon at
embryonic day (E) 14. (A-D) In WT CTX, but not GE, precursors
are Ngn2-immunopositive (red), while precursors in the GE, but not
the CTX, are Mash1-immunoreactive (green in A-D). Panels from
littermate mutant mice are depicted in the right column (A′-D′). Note
that Ngn2-immunoreactivity is not detectable in the CTX of mutant
mice with a large deletion in the PD (see Fig. 1B), the Pax6Aey18–/–
mice (A′) and the functional null allele Pax6Sey–/– (E′), while it is
unaffected in Pax6(5a)–/– (B′) and Pax64Neu–/– (C′). Conversely,
Mash1-immunoreactivity spreads ectopically into the cortex of
Pax6Aey18–/– (A′) and Pax6Sey–/– (D′) mice, but is not changed in
Pax6(5a)–/– (B′) or Pax64Neu–/– (C′) telencephalon. Thus, the PD of
Pax6 seems to be necessary and sufficient to exert patterning of the
telencephalon. The dashed white line (A,B,B′,C,C′) indicates the
ventricular surface. CTX, cortex; GE, ganglionic eminence. Scale
bar: 100 µm.
Fig. 4. SFRP2 expression in the pallio-subpallial boundary between
the dorsal (CTX) and ventral (GE) telencephalon of mice harboring
mutations in the distinct DNA-binding domains of Pax6.
Micrographs depict in situ-hybridization for SFRP2 mRNA in
coronal sections of the telencephalon of WT and mutant littermates
as indicated in the panel at embryonic day (E) 14. Note that SFRP2
expression is highest at the boundary between CTX and GE in WT
mice (A,B,C,D; arrowhead in A), and Pax6(5a)–/– (B′), while its
expression is lost at this position in the Pax6 mutation with a large
deletion in the PD Pax6Aey18–/– (A′), the mutation with the defect HD
Pax64Neu–/– (C′) and the functional null allele Pax6Sey–/– (D′). Thus,
both, DNA binding of the PD and the HD of Pax6 are required for
SFRP2 expression at the pallial-subpallial boundary. CTX, cortex;
GE, ganglionic eminence. Scale bar: 100 µm.
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the HD mutant Pax64Neu–/– (data not shown). Taken together,
these results suggest that the HD and the PD cooperate on
some, but not all aspects of differentiation of the dorso-ventral
telencephalic boundary, while the other effects of Pax6
on dorso-ventral patterning mediated by region-specific
expression of transcription factors are predominantly regulated
by the PD.
Gain-of-function experiments reveal a specific role
of the PD5a in proliferation but not in cell fate
Since the canonical form of the PD can bind to both P6CON
and 5aCON (Epstein et al., 1994), we were concerned whether
upregulation of canonical Pax6 in the Pax6(5a)–/– may
compensate for the lack of the Pax6(5a) isoform. Indeed, real-
time RT-PCR analysis revealed a relative increase in Pax6
mRNA in the Pax6(5a)–/– cortex that may be sufficient to
compensate for the small amount (10-20%) of the Pax6(5a)
isoform during most of neurogenesis in the developing cortex
(see Fig. S3 in supplementary material). We therefore chose
gain-of-function experiments to directly assess the specific
effect of the Pax6(5a) isoform. Replication-incompetent
retroviral vectors were used to overexpress Pax6(5a) in
individual precursor cells to examine the influence on the
progeny of these individual precursors. As indicated in Fig. 5A,
single precursor cells from the cerebral cortex isolated at E14
were infected with one of the retroviral vectors carrying the
LacZ marker gene encoding for β-galactosidase (βGal) (Fig.
5B), and their progeny were detected as distinct clusters of
βGal immunoreactive cells, each representing a clone, after
one week in vitro (Heins et al., 2001; Heins et al., 2002;
Williams et al., 1991). Besides the control construct, viral
vectors containing the canonical form of Pax6 (Hack et al.,
2004; Heins et al., 2002) or the Pax6(5a) isoform (see Materials
and methods), an IRES sequence and the marker gene (Fig. 5B)
were used. This experiment assessed the cell-autonomous
effects of the two isoforms of the PD on cell fate and cell
proliferation by analysing the type and number of descendants
generated by a single infected precursor cell.
The cell types generated by infected precursors were
identified by immunocytochemistry using anti-NeuN for
neurons, O4 for oligodendrocytes, anti-GFAP for astrocytes
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Fig. 5. Retroviral overexpression of Pax6(5a) reveals a distinct
influence on cell proliferation without effects on cell fate.
(A) Corresponding micrographs of a clone of cells (indicated by
arrow), isolated from the embryonic day (E) 14 cortex, infected with
the BAG control retrovirus (upper row), Pax6-containing retrovirus
(middle row) and Pax6(5a)-containing virus (lower row), cultured for
7 days in vitro and immunostained against β-galactosidase (β-gal,
green), NeuN (red). Scale bar: 50 µm. (B) Schematic drawings of the
retroviral constructs used for control, Pax6 (canonical form of PD)
and Pax6(5a) overexpression together with the marker gene lacZ. (C)
Histogram depicting the clone type of either control (BAG), Pax6- or
Pax6(5a)-infected cells isolated from E14 WT (bars to the left) or
Pax6Sey–/– mutant cortex (bars to the right) and cultured for 7 days.
Note that the percentage of pure neuronal clones (blue bars)
increases significantly (compared to WT control, t-test, see Materials
and methods; error bars=s.e.m.) in the cells transduced with virus
containing Pax6 with the canonical form of the PD, at the expense of
the mixed (yellow bars) and pure non-neuronal clones (red bars). In
contrast, Pax6(5a) exerted no effect on the clone type, even in the
absence of functional Pax6 in Pax6Sey–/– cortical cells.
(D) Histogram depicting the mean size of clones (=the number of β-
galactosidase-positive cells per clone, i.e. the number of cells
generated by a single infected precursor) in the cultures described in
C. Note that the clone size was reduced after transduction of cortical
cells with Pax6 and Pax6(5a). Pax6(5a) was sufficient to reduce cell
proliferation, suggesting that this effect is mediated by the 5aCON
site. Numbers of clones analyzed: WT Ctrl: 395, WT Pax6: 243, WT
Pax6(5a): 268, Pax6Sey–/– Ctrl: 353, Pax6Sey–/– Pax6: 229, Pax6Sey–/–
Pax6(5a): 219.
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and RC2 or anti-nestin for undifferentiated precursors. Clones
were classified as pure neuronal clones when all cells of a
cluster were NeuN-positive (examples in Fig. 5A), as mixed
when only some cells of a cluster were NeuN-positive, and as
non-neuronal when no cell of a cluster was NeuN-positive
(Heins et al., 2001; Heins et al., 2002). Note that Pax6
containing the canonical PD potently increased neurogenesis
and the number of neuronal clones as described previously
(Heins et al., 2002), while Pax6(5a) overexpression had no
effect on neuronal or glial cell fate (Fig. 5C). While the
canonical form of Pax6 almost completely suppressed the
generation of oligodendrocytes (0% of clones, n=81) or
astrocytes (3% of clones, n=249), precursors infected with the
Pax6(5a) form still generated control levels of oligodendrocyte
clones (7% of clones, n=103) or astrocytes (11% of clones,
n=137). One transcription factor involved in cell fate and the
regulation of patterning is Mash1 (Casarosa et al., 1999) that
normally is reduced after Pax6 overexpression (Heins et al.,
2002). Only cells infected with the virus containing Pax6 with
the canonical PD downregulated Mash1 (2% of clones, control
14%) while no change in Mash1-immunoreactive cells could
be observed in the Pax6(5a)-infected cells (18% of clones). The
absence of any effect of Pax6(5a) on cell fate was further
confirmed in rescue experiments performed in cortical cells
from Pax6Sey–/– mice (Fig. 5C), where the low degree of
neurogenesis could only be rescued by introduction of the
canonical form of Pax6, while the Pax6(5a) form showed no
effect at all (Fig. 5C). Taken together, these data demonstrate
that even after overexpression in a Pax6 functional null
background, Pax6(5a) is not able to influence cell fate of
cortical progenitors. This suggests that the targets important for
the mediation of the potent neurogenic role of Pax6 are
regulated by the consensus site that is exclusively bound by the
canonical PD of Pax6, i.e. the P6CON site.
In contrast to the lack of effect on cell fate, Pax6(5a)
retroviral transduction exerted a potent effect on cell
proliferation. The clone size reflects the number of the progeny
generated by a single infected precursor and is significantly
reduced by overexpression of both forms of Pax6, the canonical
PD or the PD with the 5a insert (Fig. 5D). Pax6(5a)
overexpression leads to a reduction in clone size independent
of their cell type, i.e. in both neuronal and glial clones. While
neuronal clones were typically small (see examples in Fig. 5A)
(Heins et al., 2001; Heins et al., 2002), oligodendrocyte-
containing clones are much larger and had a mean clone size
of 16 cells in cultures infected with the control virus but only
11 cells in Pax6(5a)-infected cultures. Thus, Pax6(5a) reduces
cell proliferation independent of the cell fate, while the
canonical form of Pax6 couples both effects.
Discussion
Our functional analysis of the distinct DNA-binding domains
of Pax6 showed that the canonical form of the PD regulates
coordinately, neurogenesis, cell proliferation and patterning in
the developing telencephalon, while the spliced form of the PD
[Pax6(5a)] affects specifically cell proliferation without any
effects on cell fate and regionalization (Fig. 6). In contrast,
mutation of the HD affected only subtle aspects of the
boundary delineating the dorsal and ventral telencephalon.
Since the canonical form of the PD binds to both Pax6
consensus sites (P6CON, 5aCON) and the Pax6(5a) isoform
binds exclusively to the 5aCON site (Epstein et al., 1994), our
results suggest that the regulation of neurogenesis and the
forebrain patterning is mediated via target genes containing
P6CON sites, whereas the regulation of proliferation is
mediated by target genes containing 5aCON sites (Fig. 6).
Homeodomain targets play minor roles in the
developing telencephalon
Our analysis of the Pax64Neu–/– mutant, which carries a point
mutation in the third helix of the HD that abolishes its DNA
binding (Favor et al., 2001), revealed that DNA binding of the
HD plays no role in the regulation of neurogenesis and cell
proliferation in the developing forebrain, but is required
together with the PD for the differentiation of one aspect of
boundary formation in the forebrain, namely the expression of
SFRP2. SFRP2 is a wnt-inhibitor expressed at the border
between the dorsal and the ventral telencephalon. In both, the
PD (Pax6Aey18–/–) and HD (Pax64Neu–/–) mutant mice SFRP2
failed to be expressed at this position, while it was apparent
in other parts of the brain. Other aspects of boundary
differentiation, such as reticulon-1 expression or high BLBP-
content in fasciculating radial glia fibers (data not shown), were
Fig. 6. Summary of the specific roles of the Pax6 DNA-binding
domains in telencephalic development. Analysis of the Pax6Aey18–/–
mutant showed that the PD of Pax6 (A,B) is important for the
regulation of neurogenesis, proliferation and regionalization in the
developing telencephalon and that it contributes to the formation of
the pallio-subpallial boundary. The lack of a phenotype in
neurogenesis and proliferation in the forebrain of Pax64Neu–/– mice
showed that the HD has no role in these processes (A), but is
involved in some aspects of the pallio-subpallial boundary formation
(SFRP2 expression). The Pax6(5a) isoform (B) is generated by
alternative splicing leading to the insertion of a 14 AA insert in the
N-terminal PAI subdomain of the PD, abolishing DNA binding and
thereby favoring DNA binding via the RED domain. Retroviral
overexpression revealed the anti-proliferative role of the Pax6(5a)
isoform in cortical cells.
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normal in the HD mutant Pax64Neu–/–, suggesting that DNA
binding of the HD is required only for some aspects of
boundary specification. Since both HD and PD mutations fail
to regulate SFRP2, either both DNA-binding domains may
need to bind cooperatively to mediate transcription of SFRP2,
or an intact PD is required for the appropriate modulation of
HD DNA binding as previously demonstrated in vitro (Jun and
Desplan, 1996; Singh et al., 2000; Mishra et al., 2002). These
results further support the multitude of regulatory mechanisms
contributing to the boundary formation at this position that may
also act as an organizing centre in the developing telencephalon
(Assimacopoulos et al., 2003).
The canonical form of the paired domain is
necessary and sufficient for the regulation of
neurogenesis and cell proliferation
The novel Pax6 mutation Pax6Aey18 (J.G., unpublished) with a
PD lacking most of its DNA-binding domain but intact HD
and TA resulted in the same telencephalic phenotype as in the
Pax6 functional null allele Pax6Sey–/– (Estivill-Torrus et al.,
2002; Götz et al., 1998; Stoykova et al., 1996; Stoykova et al.,
2000). Even at the quantitative level, no differences in
neurogenesis and cell proliferation were detectable between
Pax6Aey18–/– and Pax6Sey–/– cortices, suggesting that the PD
alone is necessary and sufficient for all of these aspects of
cortical development. In addition, both genotypes expressed
similar severity in the disturbance of patterning in the
telencephalon. Our results therefore demonstrate that targets
of the PD are necessary and sufficient to regulate cell
proliferation and cell fate, comprising neurogenesis and
patterning, in the developing forebrain.
Targets of the 5aCON site are involved in the
regulation of cell proliferation in the developing
telencephalon
Given the predominant role of the PD in exerting the Pax6
functions in forebrain development, we further determined the
specific role of the 5a splice insert into the PD that shifts DNA
binding from the N-terminal to the C-terminal domain of the
PD (Epstein et al., 1994), by analysis of the Pax6(5a)–/– mice
(Singh et al., 2002). We did not detect any changes in
neurogenesis, cell proliferation and regionalization in the
Pax6(5a)–/–. This finding has to be interpreted with caution,
since the mRNA of the canonical form of Pax6 was upregulated
(1,4-fold) in amounts sufficient to compensate for the lack of
Pax6(5a) in Pax6(5a)–/– mice. Messenger RNA of Pax6(5a)
comprises about 10-20% of the total Pax6 mRNA (E10-E12,
see Fig. S3 in supplementary material), a ratio previously
observed to be rather effective for transcriptional regulation
(Chauhan et al., 2004). From our in vivo analysis we can
therefore only conclude that there are no specific roles of the
Pax6(5a) isoform that could not also be exerted by the
canonical PD in the developing forebrain. Indeed, Pax6(5a)
affects solely a subset of the functions of the canonical form
of Pax6. Overexpression of Pax6(5a) in individual cortical
precursor cells showed a specific and cell-autonomous effect
on the number of progeny of a single precursor, without
affecting cell fate even in the absence of functional Pax6 in the
Pax6Sey–/– background. This phenotype, the reduction of clone
size, can be due to three mechanisms – an increase in cell
death, an increase in postmitotic cells or an increase in
asymmetric rather than symmetric cell divisions. We observed
no difference in cell death as analyzed by DAPI staining, but
discovered a significant reduction of proliferating cells in the
Pax6-transduced clones already 2 days after infection (71%
proliferating cells amongst all control virus infected cells
compared to 53% after Pax6 overexpression). Thus, Pax6 and
Pax6(5a) overexpression increases the number of cells leaving
the cell cycle either due to an increase in asymmetric cell
division or a lengthening of cell cycle (Calegari and Huttner,
2003). Both effects could also explain the increase in the
number of precursors seen in the Pax6 loss-of-function
mutations (Götz et al., 1998; Estivill-Torrus et al., 2002).
Further experiments are needed to clarify the exact role of Pax6
on cell cycle length or the mode of cell division in proliferating
precursors. Since the Pax6(5a) form is sufficient to induce
these changes in proliferation and binds exclusively to the
5aCON site, these data demonstrate that targets of the 5aCON
site are specifically involved in the regulation of cell
proliferation, while targets of the P6CON site seemingly
regulate neurogenesis. The latter is consistent with the role of
Ngn2, a target containing the P6CON site, in neurogenesis
(Bertrand et al., 2002).
PD, PD5a and HD act in a context-specific manner
during forebrain and eye development
The effect on cell proliferation depends on the CNS region –
while Pax6 negatively regulates proliferation in the
telencephalon, it promotes proliferation in the vertebrate
(Marquardt et al., 2001) and invertebrate (Dominguez et al.,
2004) eye. This is also the case for the Pax6(5a) isoform. The
deletion of exon 5a results in reduced number of iris and lens
fiber cells in the eye (Singh et al., 2002), consistent with its
proliferation promoting effect. Similarly, in the Drosophila
eye eyegone and the murine Pax6(5a) positively affect cell
proliferation (Dominguez et al., 2004). Thus, the positive
effect of the 5aCON targets on cell proliferation in the eye is
widespread across vertebrates and invertebrates, while the
Pax6(5a)-mediated reduction of cell proliferation observed in
precursors of the developing mouse telencephalon seems to be
more specific and may have evolved more recently. The HD
of Pax6 plays an important role in the eye (Favor et al., 2001),
but not in the developing forebrain. Favor and colleagues
(Favor et al., 2001) showed that the Pax64Neu mutation leads
to severe defects in eye formation with homozygous mice
developing no eye, except a remnant of the retinal
neuroepithelium (pseudo-optic cup), suggesting that targets of
the HD are important for both the early role of Pax6 in the
surface ectoderm for lens formation, and later processes
during retina specification (Ashery-Padan and Gruss, 2001;
Ashery-Padan et al., 2000; van Heyningen and Williamson,
2002). Our analysis has further shown reduced proliferation
and Ngn2 immunoreactivity in the remnant of the retinal
neuroepithelium in the Pax64Neu–/– (data not shown), similar
to the phenotype in the PD mutant Pax6Aey18–/–. Both the PD
and HD are thus important for the regulation of proliferation
and cell fate in the retina, while the HD plays no role in these
aspects in the telencephalon. In conclusion our results thus
imply the selective use of PD, PD5a and HD targets as one
mechanism that may contribute to the region-specific
differences in Pax6 function within the CNS as well as in
different organs.
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